Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2026-03-09

Clinical Trial Update: Intrathecal Hydromorphone vs Intrathecal Morphine to Treat Post Cesarean Pain in Patients With Opioid Use Disorder Taking Buprenorphine [Phase 4]

View source ↗

Summary

Phase 4 trial comparing intrathecal hydromorphone to intrathecal morphine for post-cesarean pain in patients with opioid use disorder on buprenorphine has been …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hydromorphone (hydromorphone)
  • Morphine (morphine)

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Opioid Use Disorder | Phase 4 | Status: WITHDRAWN